---
figid: PMC11789290__10020_2025_1088_Fig8_HTML
figtitle: NUAK1-mediated PD-L1 expression in HCC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11789290
filename: 10020_2025_1088_Fig8_HTML.jpg
figlink: /pmc/articles/PMC11789290/figure/F8/
number: F8
caption: Schematic representation of NUAK1-mediated PD-L1 expression in HCC. NUAK1
  enhances the transcriptional expression of PD-L1 by activating the GSK3β/β-catenin
  signaling pathway, thereby suppressing cytotoxic T cell activity within the tumor
  microenvironment and facilitating immune evasion in hepatocellular carcinoma
papertitle: NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin
  pathway in hepatocellular carcinoma
reftext: Chao-Yan Yao, et al. Mol Med. 2025;31(NA).
year: '2025'
doi: 10.1186/s10020-025-01088-7
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: The Feinstein Institute for Medical Research
keywords: NUAK1 | GSK3β | Β-catenin | PD-L1 | Hepatocellular carcinoma
automl_pathway: 0.9488226
figid_alias: PMC11789290__F8
figtype: Figure
redirect_from: /figures/PMC11789290__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11789290__10020_2025_1088_Fig8_HTML.html
  '@type': Dataset
  description: Schematic representation of NUAK1-mediated PD-L1 expression in HCC.
    NUAK1 enhances the transcriptional expression of PD-L1 by activating the GSK3β/β-catenin
    signaling pathway, thereby suppressing cytotoxic T cell activity within the tumor
    microenvironment and facilitating immune evasion in hepatocellular carcinoma
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - GSK3A
  - GSK3B
  - CD274
  - NUAK1
  - CTNNB1
  - HNF4A
---
